SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Surges 4.67% Today

SAI LIFE SCIENCES LIMITED Share Price rises 4.67% to Rs 1,289.8, with a market cap of Rs 26,161.1 crore.

SAI LIFE SCIENCES LIMITED Share Price has experienced a notable increase of 4.67% today, reaching Rs 1,289.8. This significant price movement places the company in the spotlight, especially given its large-cap status with a market capitalisation of Rs 26,161.1 crore. The stock's performance today has surpassed the qualifying threshold of 3% set for large-cap stocks, making it a top gainer in the market. Investors and analysts are keenly observing this development, as the price rise could indicate underlying factors influencing the stock's trajectory.

SAI LIFE SCIENCES LIMITED Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,289.8
Previous Close	Rs 1,232.3
Today's Change	+Rs 57.5 (+4.67%)
Day Open	Rs 1,255.75
Day High	Rs 1,290.9
Day Low	Rs 1,244.7
Current Volume (BSE)	96,428
BSE Traded Volume	96,428
NSE Traded Volume	4,02,039
Combined NSE + BSE Volume	4,98,467
Turnover	Rs 12.44 crore
Market Capitalisation	Rs 26,161.1 crore
Market Cap Category	Large Cap
Qualifying Threshold Cleared	3%

Today's trading session for SAI LIFE SCIENCES LIMITED opened at Rs 1,255.75 and saw the stock reach a high of Rs 1,290.9 before settling at Rs 1,289.8. The previous close was Rs 1,232.3, marking a day change of Rs 57.5. The stock's day low was Rs 1,244.7, indicating a range of volatility throughout the session. The total turnover for the day was Rs 12.44 crore, with a total volume of 498,467 shares traded across both BSE and NSE. The volume ratio suggests heightened trading activity, as the current volume significantly exceeds the average. This price action, coupled with the stock's large-cap classification, highlights its prominence in the market today.

SAI LIFE SCIENCES LIMITED Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 26,161.1 crore
P/E Ratio	31.07x
P/B Ratio	2.36x
ROE	29.2%
ROCE	27.13%

SAI LIFE SCIENCES LIMITED was valued at a P/E ratio of 31.07x, a P/B ratio of 2.36x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 29.2% and ROCE of 27.13%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

SAI LIFE SCIENCES LIMITED, with a market cap of Rs 26,161.1 crore, is a significant player in the healthcare sector. The company's P/E ratio stands at 31.07, which is above the sector median of 20.79 but aligns with the sector's average. The P/B ratio of 2.36 is slightly above the sector median of 1.89, indicating a higher valuation relative to book value. The company's ROE of 29.2% and ROCE of 27.13% are significantly above the sector medians, showcasing strong profitability and efficient capital use. These fundamentals suggest that SAI LIFE SCIENCES LIMITED is well-positioned within its sector, attracting investor attention due to its robust financial metrics.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Companies in Benchmark	203
Company P/E Ratio	31.07x
Benchmark Median P/E	20.79x
Benchmark Average P/E	67.01x
Benchmark P/E Range	0x to 3,482.29x
Companies with P/E Data	203
Company P/B Ratio	2.36x
Benchmark Median P/B	1.89x
Company ROE	29.2%
Benchmark Median ROE	10.69%
Company ROCE	27.13%
Benchmark Median ROCE	13.12%
Company Market Capitalisation	Rs 26,161.1 crore
Benchmark Median Market Cap	Rs 130.49 crore

SAI LIFE SCIENCES LIMITED (SAILIFE) is classified under sector: Healthcare. The numerical benchmark uses 203 same sector companies from the supplied master-data set.

SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 31.07x, which is above the benchmark median of 20.79x, a difference of +49.45%. The benchmark contains 203 companies with P/E data, ranging from 0x to 3,482.29x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROE of 29.2%, which is above the benchmark median of 10.69%, a difference of +173.15%. SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROCE of 27.13%, which is above the benchmark median of 13.12%, a difference of +106.78%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

SAI LIFE SCIENCES LIMITED operates within the healthcare sector, which comprises 203 companies. The sector's P/E median is 20.79, with an average of 67.01, highlighting the diverse valuation landscape. The company's P/E ratio of 31.07 is above the median, suggesting a relatively higher valuation. The sector's P/B median is 1.89, with an average of 2.78, positioning SAI LIFE SCIENCES LIMITED's P/B ratio of 2.36 in the upper range. The company's ROE and ROCE are well above the sector averages, indicating superior performance. This context underscores the company's competitive standing within the healthcare sector.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Morepen Laboratories Ltd.	MOREPENLAB	2,947.44	31.07	2.36	29.2	27.13
Dishman Carbogen Amcis Ltd.	DCAL	2,885.59	29.61	0.43	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,881.37	42.78	8.71	28.21	26.35
Beta Drugs Ltd.	BETA	2,567.04	61.88	8.27	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,425.38	34.6	7	-2.6	16.92

SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 31.07x compared with the displayed peer median of 34.6x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 29.2% compares with a peer median of 18.65% across the companies shown in the table. ROCE stood at 27.13% versus the displayed peer median of 22.17%, providing a capital-efficiency comparison. SAI LIFE SCIENCES LIMITED (SAILIFE) has a market capitalisation of Rs 26,161.1 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

In comparison to its peers, SAI LIFE SCIENCES LIMITED holds a strong position. Morepen Laboratories Ltd. shares the same P/E and P/B ratios, with similar ROE and ROCE figures, highlighting comparable financial health. Dishman Carbogen Amcis Ltd. has a lower P/E and P/B but negative ROE and ROCE, indicating challenges. Kwality Pharmaceuticals Ltd. shows a higher P/E and P/B with strong profitability metrics. Beta Drugs Ltd. has a higher P/E and P/B, with moderate ROE and ROCE. These comparisons illustrate SAI LIFE SCIENCES LIMITED's balanced valuation and strong profitability relative to its peers.

Why Investors Are Watching SAI LIFE SCIENCES LIMITED

Investors are closely monitoring SAI LIFE SCIENCES LIMITED due to its recent price surge and strong financial metrics.

• Price Action: Share price increased by 4.67% today.
• Technical Position: Significant trading volume and turnover.
• Fundamental Context: Strong ROE and ROCE above sector averages.
• Sector Positioning: Competitive standing within the healthcare sector.

Investors should continue to monitor SAI LIFE SCIENCES LIMITED's performance, particularly any developments in the healthcare sector that could impact its valuation and market position.

About SAI LIFE SCIENCES LIMITED

SAI LIFE SCIENCES LIMITED is a prominent entity in the healthcare sector, focusing on pharmaceutical and drug development. The company operates across various segments, providing innovative solutions and products that cater to diverse medical needs. Its robust market presence and strategic initiatives have positioned it as a key player in the industry. With a commitment to quality and innovation, SAI LIFE SCIENCES LIMITED continues to expand its footprint, leveraging its expertise to drive growth and deliver value to stakeholders.

Track SAI LIFE SCIENCES LIMITED Share Price on Univest

Use SAI LIFE SCIENCES LIMITED (SAILIFE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track the live share price of SAI LIFE SCIENCES LIMITED on Univest, along with technical indicators, fundamental ratios, and shareholding patterns. Univest provides comprehensive market insights, including 52-week levels and sector analysis, enabling informed investment decisions.

Frequently Asked Questions

What is the current share price of SAI LIFE SCIENCES LIMITED?

Ans. The current share price of SAI LIFE SCIENCES LIMITED is Rs 1,289.8, reflecting a 4.67% increase from the previous close of Rs 1,232.3. The stock moved 4.67% during the session.

How much did SAI LIFE SCIENCES LIMITED's share price increase today?

Ans. SAI LIFE SCIENCES LIMITED's share price increased by 4.67% today, marking a significant rise in the stock's value. The stock moved 4.67% during the session. The intraday range extended from Rs 1,244.7 to Rs 1,290.9.

What is the market capitalisation of SAI LIFE SCIENCES LIMITED?

Ans. The market capitalisation of SAI LIFE SCIENCES LIMITED is Rs 26,161.1 crore, categorising it as a large-cap company. The company operates in the Healthcare sector. Its P/E ratio is 31.07x.

What is the P/E ratio of SAI LIFE SCIENCES LIMITED?

Ans. SAI LIFE SCIENCES LIMITED has a P/E ratio of 31.07, which is above the sector median of 20.79, indicating a higher valuation. The company trades at a P/E ratio of 31.07x.

How does SAI LIFE SCIENCES LIMITED's ROE compare to the sector?

Ans. SAI LIFE SCIENCES LIMITED's ROE of 29.2% is significantly above the sector median of 10.69%, showcasing strong profitability. ROE stands at 29.2%. ROCE stands at 27.13%. The relevant peer median ROE is 10.69%.

How does SAI LIFE SCIENCES LIMITED's P/B ratio compare to the sector?

Ans. SAI LIFE SCIENCES LIMITED's P/B ratio of 2.36 is above the sector median of 1.89, suggesting a higher valuation relative to book value. The company trades at a P/E ratio of 31.07x.

What is the sector benchmark for P/E ratio?

Ans. The sector benchmark for P/E ratio has a median of 20.79 and an average of 67.01, highlighting the valuation range within the healthcare sector. The company trades at a P/E ratio of 31.07x.

Who are some of SAI LIFE SCIENCES LIMITED's peers?

Ans. Some peers of SAI LIFE SCIENCES LIMITED include Morepen Laboratories Ltd., Dishman Carbogen Amcis Ltd., and Kwality Pharmaceuticals Ltd. Comparable listed companies include Morepen Laboratories Ltd., Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd.